This is a past event. Registration is closed. View other NewYorkBIO events.
- Tours of the Incubator
Arrive before the programing to take a quick tour of the Incubator @ CBLS.
- Welcome Remarks
Jennifer Hawks BlandWelcome remarks from NewYorkBIO's CEO, Jennifer Hawks Bland
Jennifer Hawks Bland
Chief Executive Officer at NewYorkBIO
- Intro to the Incubator @ CBLS
Dr. Roberto PiliLearn about the Incubator @ CBLS and the great work being done by the team at University of Buffalo.
Dr. Roberto Pili
Associate Dean for Cancer Research and Integrative Oncology at University at Buffalo
- Vision Talk: "New strategies to improve the safety and efficacy of anti-cancer antibodies and antibody-drug conjugates"
Dr. Joseph BalthasarA TED style talk from an industry professional.
Dr. Joseph Balthasar
David and Jane Chu Endowed Chair in Drug Discovery and Development Director of the Center for Protein Therapeutics Executive Director, University Research Initiatives Co-founder and President at Abceutics Inc.
- Panel Discussion: Financing the Next Generation of Oncology Companies
Christine E.B. Howard•Scott E. Friedman•John Seman•Dr. Joseph ConradToday’s biotech companies face additional market hurdles when accessing capital. Therefore, to fund treatments and cures, especially in areas outside the traditional home bases of venture and investors, companies must be creative. This panel discussion, will examine the challenges and opportunities of accessing capital via traditional routes, partnerships and grants in the context of today’s evolving market through the unique lens of emerging biotech companies.
Christine E.B. Howard
Founder & CEO of E.B. Howard Consulting
Scott E. Friedman
Partner and Team Leader: Startups/VC and Family Business at Lippes Mathias
John Seman
CEO of Canget BioTekpharma
Dr. Joseph Conrad
Senior Technology Analysis & Marketing Specialist Technology Analysis & Marketing Unit at National Cancer Institute
- Break
Networking Break
- Vision Talk "Depth and Breadth of the NIH"
Dr. Joseph ConradA TED style talk from an industry professional.
Dr. Joseph Conrad
Senior Technology Analysis & Marketing Specialist Technology Analysis & Marketing Unit at National Cancer Institute
- Panel Discussion: Bench to Bedside
Ketan Gujarathi•Jennifer Hawks Bland•Kelley Purdom•Dr. Mike SmolinskiFrom the early stages of research done in the laboratory to a therapeutic treating a patient’s cancer the drug discovery process is long. We will talk about the journey from an idea to life-changing ways to treat patients.
Ketan Gujarathi
Executive Director of Cell Therapy Operations at BMSJennifer Hawks Bland
Chief Executive Officer at NewYorkBIO
Kelley Purdom
Executive Director, Clinical Study Group Lead, Oncology and Rare Disease of Pfizer
Dr. Mike Smolinski
- Break
- Panel Discussion: Patients and Policy
Michael Davoli•Rachael Eckles•Ken SchlosserPolicymakers consider several different angles when crafting legislation that often has a broad impact on patients, our healthcare system, and the companies in the oncology space. While there are several factors that contribute to the value of a particular therapy or intervention, a patient’s lived experience can make a lasting impact on an elected official or policy maker. The panel will discuss potential ways to impact change and move the needle on policy issues facing the oncology industry over the coming decade.
Michael Davoli
Senior Government Relations Director of American Cancer Society Cancer Action Network
Rachael Eckles
Senior Director/Team lead in Therapeutic Area policy team in US Policy & Government Affairs of Bristol Myers Squibb Company
Ken Schlosser
- Closing Remarks
Jennifer Hawks BlandClosing remarks from NewYorkBIO CEO, Jennifer Hawks Bland.
Jennifer Hawks Bland
Chief Executive Officer at NewYorkBIO
- Networking Reception
Join us for cocktails and passed hors d'oeuvres